This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shalit, I Articles by Marks, M I Search for Related Content PubMed PubMed Citation Articles by Shalit, I Articles by Marks, M I

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1985 June; 27(6): 908-911

In vitro antibacterial activities of antibiotics against Pseudomonas aeruginosa in peritoneal dialysis fluid.

I Shalit, D F Welch, V H San Joaquin and M I Marks

ABSTRACT

Intraperitoneal antibiotics are used to treat Pseudomonas aeruginosa peritonitis, a serious complication of continuous ambulatory peritoneal dialysis. However, P. aeruginosa killing is often inefficient despite low MBCs. Broth dilution MIC/MBC and time kill curves of tobramycin, amikacin, netilmicin, azlocillin, piperacillin, ceftazidime, cefsulodin, and ciprofloxacin were determined in peritoneal dialysis fluid (PDF), buffered PDF, fluid recovered from patients on continuous ambulatory peritoneal dialysis (RPF), and cation-supplemented Mueller-Hinton broth. MBCs of all antibiotics were 8 to 16 times greater in PDF and RPF than in Mueller-Hinton broth or buffered PDF. Use of the time kill curve technique and Mueller-Hinton broth showed that aminoglycosides killed greater than or equal to 99.9% of P. aeruginosa at 1 h, ciprofloxacin killed greater than or equal to 99.9% at 2 h, and beta-lactams killed greater than or equal to 99.9% at 6 h. In contrast, killing was not demonstrated in PDF by any drug at 6 h and by aminoglycosides only at 24 h. Bactericidal activity was optimal in RPF for ciprofloxacin at 1 h and for aminoglycosides at 2 h; bactericidal activity was not demonstrated in RPF with any beta-lactam (no kill by penicillins; less than 99% kill by cephalosporins). Slow bacterial growth, increased protein binding, and glucose concentrations and other inhibitors may interfere with beta-lactam activity in RPF. These considerations and reported clinical failures and toxicity of aminoglycoside therapy warrant further study of quinolones and drug combinations in P. aeruginosa peritonitis.

---

Antimicrob Agents Chemother. 1985 June; 27(6): 908-911

This article has been cited by other articles:

• Bulitta, J. B., Ly, N. S., Yang, J. C., Forrest, A., Jusko, W. J., Tsuji, B. T. (2009). Development and Qualification of a Pharmacodynamic Model for the Pronounced Inoculum Effect of Ceftazidime against Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 53: 46-56 [Abstract] [Full Text]  
• Strijack, C., Harding, G. K. M., Ariano, R. E., Zelenitsky, S. A. (2004). Peritoneal Fluid Titer Test for Peritoneal Dialysis-Related Peritonitis. Antimicrob. Agents Chemother. 48: 1719-1726 [Abstract] [Full Text]  
• Hermsen, E. D., Hovde, L. B., Hotchkiss, J. R., Rotschafer, J. C. (2003). Increased Killing of Staphylococci and Streptococci by Daptomycin Compared with Cefazolin and Vancomycin in an In Vitro Peritoneal Dialysate Model. Antimicrob. Agents Chemother. 47: 3764-3767 [Abstract] [Full Text]  
• Zelenitsky, S., Franczuk, C., Fine, A., Ariano, R., Harding, G. (2002). Antibiotic tolerance of peritoneal bacterial isolates in dialysis fluids. J Antimicrob Chemother 49: 863-866 [Abstract] [Full Text]